Glaxosmithkline Pharmaceuticals has informed that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is closed from Monday, 1st January, 2018 and shall reopen on Wednesday, 7th February, 2018 i.e. after the approval and declaration of Un-Audited Financial Results for the third quarter and nine months ended 31st December, 2017, by the Board of Directors at its meeting scheduled to be held on 2nd February, 2018.
The above information is a part of company’s filings submitted to BSE.
